Archives
-
Adipose-Neural Signaling in Cardiac Arrhythmia
2026-09-08
Fan et al. establish a stem cell-based coculture model showing how epicardial adipose tissue can influence cardiomyocyte arrhythmia through a leptin–sympathetic neuron–NPY–Y1R pathway. The study connects adipocyte signaling with NCX and CaMKII activity and provides patient-level evidence linking increased epicardial adipose tissue, leptin, and NPY with atrial fibrillation.
-
EPZ5676 for Reliable DOT1L Assays
2026-09-07
Learn how EPZ5676 (SKU A4166) can improve interpretation of DOT1L inhibition, H3K79 methylation, and leukemia-cell viability assays. This scenario-based guide covers mechanism, solvent compatibility, dose design, cross-study comparisons, and practical product-selection criteria.
-
Sulfachloropyridazine: From DHPS to Microbiome Insight
2026-09-07
A translational framework for connecting Sulfachloropyridazine-mediated DHPS inhibition with antimicrobial phenotypes, cecal microbiome changes, metabolomics, and better-designed infection studies.
-
CCK8 Workflow for Hepatocyte Viability Studies
2026-09-05
Build a sensitive CCK8 workflow for quantifying hepatocyte viability, proliferation, and toxicant response without a formazan solubilization step. This guide translates PFBS-induced mitochondrial injury findings into practical plate design, orthogonal validation, and troubleshooting decisions.
-
ATS-9R for Adipose Gene Silencing
2026-09-04
ATS-9R enables non-viral nucleic acid delivery with a practical focus on white adipose tissue, mature adipocytes, and visceral adipose tissue macrophages. This guide translates its Prohibitin-mediated targeting into reproducible workflows for inflammation, insulin resistance, and metabolic disease models.
-
SGI-1027 and Everolimus in Renal Cancer
2026-09-04
A study in Advanced Science identifies SGI-1027 as a methuosis inducer and shows that it cooperates with everolimus to suppress renal cancer through lysosomal membrane permeability, apoptosis, and GSDME-dependent pyroptosis. The work provides a mechanistic framework for combining mTOR inhibition with noncanonical cell-death pathways to address treatment resistance.
-
AL-8810: A Causal Probe of FP Signaling
2026-09-03
AL-8810 is a prostaglandin F2α antagonist for dissecting FP receptor biology. This article presents an assay-first framework linking receptor blockade to endometrial vascular remodeling, ERK1/2 signaling, and MMP-2 secretion.
-
Diuron: From Photosynthesis to Renal Injury
2026-09-03
Diuron research spans photosynthetic electron transport, plant biology research, and environmental toxicology. This evidence-led guide explains how the 2025 acute kidney injury study can improve assay selection, interpretation, and responsible use of C6731.
-
Bay 11-7085: NF-κB Workflow and Applications
2026-09-02
Bay 11-7085 is a practical NF-κB activation inhibitor for connecting inflammatory signaling with cell-cycle arrest and apoptosis. This guide translates its use into reproducible cell-based workflows and shows how the probe can complement endometriosis, meningitis, and subarachnoid hemorrhage research.
-
Targeted SPP1 Inhibition in Tumor Myeloid Cells
2026-09-02
The reference study identifies a phenotypic small-molecule screening strategy for reducing SPP1 expression in tumor-associated macrophages and pairs the lead compound CANDI460 with a TAM-avid polymeric nanoconstruct. Across in vitro and murine models, this approach lowered SPP1 and produced marked tumor regression, while also illustrating the translational challenges of selectively reprogramming immunosuppressive myeloid cells.
-
L-NAME Hydrochloride in NO Signaling Assays
2026-09-01
L-NAME Hydrochloride enables controlled nitric oxide synthase blockade across vascular, cellular, and translational workflows. This guide connects dose selection and rescue controls with the FXR–KLF11–JAK2/STAT3 findings reported in contrast-induced kidney injury, while keeping mechanistic interpretation experimentally disciplined.
-
Triptolide (PG490): Practical Research Workflows
2026-09-01
Triptolide (PG490) gives cancer research and immunology teams a nanomolar tool for connecting transcriptional disruption with invasion, apoptosis, and inflammatory remodeling. This guide translates its product specifications and the latest transcription-condensate findings into practical workflows, assay controls, and troubleshooting decisions.
-
Drosophila Keap1 Nuclear Condensates Under Oxidative Stress
2026-08-31
This study identifies oxidative-stress-induced nuclear condensate formation as a previously unrecognized property of Drosophila Keap1. By combining live-cell imaging, FRAP, domain analysis, and in vitro reconstitution, the authors connect dKeap1 intrinsically disordered regions with condensate assembly while showing that the Kelch domain restrains this behavior.
-
Adamtsl3, MMP9, and Adult Cortical Plasticity
2026-08-31
The reference study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal net integrity in parvalbumin-positive interneurons, linking a schizophrenia-associated gene to MMP9-dependent extracellular-matrix remodeling. Its genetic, morphological, biochemical, and pharmacological evidence shows that Adamtsl3 loss disrupts PNNs and reopens juvenile-like cortical plasticity in adult mice.
-
Doxycycline Hyclate as a Matrix Metalloproteinases Inhibitor
2026-08-30
Doxycycline hyclate is a research-grade tetracycline derivative used as a matrix metalloproteinases inhibitor, especially in MMP-2 and MMP-9 studies of blood-brain barrier injury. Evidence from a mouse arsenic-exposure model supports its use for mechanistic BBB and neuronal-apoptosis experiments, while antiviral and antimalarial findings remain model-dependent.